ONESOURCE quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Onesource Specialty Pharma Ltd reported sales of ₹516 Cr, operating profit of ₹163 Cr (OPM 32%) and net profit of ₹57 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
ONESOURCE quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
393
426
327
376
290
428
449
516
Expenses
251
243
239
269
273
336
326
353
Operating Profit
142
183
88
106
17
92
123
163
OPM
36%
43%
27%
28%
6%
21%
27%
32%
Other Income
-94
2
2
3
-2
2
0
-1
Interest
46
33
27
34
38
23
31
35
Depreciation
69
68
68
70
70
72
72
75
Profit before tax
-67
83
-4
6
-93
0
20
53
Tax
4%
-19%
-96%
-83%
-5%
-1,630%
-23%
-9%
Net Profit
-69
98
0
10
-89
5
25
57
EPS in Rs
-6.02
8.61
-0.02
0.92
-7.74
0.4
2.18
5.01
ONESOURCE profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
132
39
172
1,445
1,422
1,684
Expenses
229
199
254
978
1,117
1,288
Operating Profit
-97
-161
-82
467
304
396
OPM
-73%
-415%
-48%
32%
21%
24%
Other Income
4
-526
-143
-94
5
-2
Interest
68
48
89
166
122
126
Depreciation
70
66
76
274
279
288
Profit before tax
-231
-800
-391
-68
-92
-20
Tax
0%
0%
0%
-73%
-20%
-
Net Profit
-231
-800
-391
-18
-74
-2
EPS in Rs
-
-
-
-1.57
-6.44
-0.15
Dividend Payout
0%
0%
0%
0%
0%
-
ONESOURCE balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
4
11
11
11
11
Reserves
392
5,869
5,893
5,820
5,909
Borrowings
562
772
1,295
1,276
1,755
Other Liabilities
468
1,005
814
1,197
910
Total Liabilities
1,426
7,657
8,013
8,304
8,586
Fixed Assets
863
6,118
6,286
6,017
6,445
CWIP
188
218
173
529
141
Investments
20
16
20
16
17
Other Assets
356
1,305
1,535
1,742
1,983
Total Assets
1,426
7,657
8,013
8,304
8,586
ONESOURCE cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
-416
-163
-107
-68
9
Cash from Investing Activity
-692
-68
511
-201
-495
Cash from Financing Activity
1,162
118
-391
412
359
Net Cash Flow
54
-112
13
143
-127
Free Cash Flow
-1,071
-207
-171
-196
-561
CFO/OP
430%
108%
130%
-13%
6%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit